يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales [ENFERMEDADES]"', وقت الاستعلام: 1.29s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  2. 2

    المساهمون: Institut Català de la Salut, [Van Cutsem E] University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. [Hochster H] Rutgers Cancer Institute, New Brunswick, USA. [Shitara K, Ohtsu A] National Cancer Center Hospital East, Chiba, Japan. [Mayer R] Dana-Farber Cancer Institute, Boston, USA. [Falcone A] Azienda Ospedaliero Universitaria Pisana, Pisa, Italy. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: Print-Electronic; application/pdf

  3. 3

    المساهمون: Institut Català de la Salut, [Ravegnini G, Gorini F, Turroni S] Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. [Fosso B] Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council, Bari, Italy. Department of Biosciences, Biotechnology and Biopharmaceutics (DBBB), University of Bari 'A. Moro', Bari, Italy. [Ricci R] Department of Pathology, Catholic University, Rome, Italy. [Serrano C] Laboratori de Recerca Translacional de Sarcoma, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pilco-Janeta DF] Laboratori de Recerca Translacional de Sarcoma, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA, Vall d'Hebron Barcelona Hospital Campus, Ravegnini, Gloria, Fosso, Bruno, Ricci, Riccardo, Gorini, Francesca, Turroni, Silvia, Serrano, Cesar, Pilco-Janeta, Daniel F., Zhang, Qianqian, Zanotti, Federica, De Robertis, Mariangela, Nannini, Margherita, Pantaleo, Maria Abbondanza, Hrelia, Patrizia, Angelini, Sabrina

    المصدر: Scientia

    وصف الملف: application/pdf; ELETTRONICO

  4. 4

    المساهمون: Institut Català de la Salut, [Fernández-Hernández JA, Cantín-Blázquez S, García-Somacarrera E, Varo-Pérez E, González-López JA, Asencio-Pascual JM] Sección de Tumores Mesenquimales y Sarcomas, Asociación Española de Cirujanos, Madrid, Spain. [Serrano C] Sarcoma Translational Research Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  5. 5

    المساهمون: [Bas-Cutrina F] Endoscopy Unit. Department of Digestive Diseases. Hospital Universitari de Bellvitge. Barcelona, Spain. Bellvitge Biomedical Research Institute (IDIBELL). Barcelona, Spain. Department of Clinical Sciences. School of Medicine and Health Sciences. Universitat de Barcelona (UB). Barcelona, Spain. Digestive Diseases Unit. Hospital General de Granollers. Granollers, Spain. [Casellas-Grau A] Psycho-oncology Service. Institut Català d’Oncologia (ICO). L’Hospitalet de Llobregat, Barcelona. Spain. Department of Psychology. School of Education, Translation, Sports and Psychology. Universitat de Vic – Universitat Central de Catalunya (UVic-UCC). Vic, Barcelona. Spain. [Videla S] Bellvitge Biomedical Research Institute (IDIBELL). Barcelona, Spain. Department of Clinical Sciences. School of Medicine and Health Sciences. Universitat de Barcelona (UB). Barcelona, Spain. Clinical Research Support Unit. Hospital Universitari de Bellvitge. L´Hospitalet de Llobregat, Barcelona. Spain. [Loras C, Andújar X] Endoscopy Unit. Department of Digestive Diseases. Hospital Universitari Mútua de Terrassa. Terrassa, Barcelona. Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). Instituto de Salud Carlos III. Madrid, Spain. [Gil FL] Psycho-oncology Service. Institut Català d’Oncologia (ICO). L’Hospitalet de Llobregat, Barcelona. Spain. Tecnocampus Mataró-Maresme Foundation. Universitat Pompeu Fabra (UPF). Barcelona, Spain. [Galán M] Department of Clinical Sciences. School of Medicine and Health Sciences. Universitat de Barcelona (UB). Barcelona, Spain. Department of Medical Oncology. Institut Català d’Oncologia (ICO). L’Hospitalet de Llobregat, Barcelona. Spain. [Fernández-Aranda F] Bellvitge Biomedical Research Institute (IDIBELL). Barcelona, Spain. Department of Clinical Sciences. School of Medicine and Health Sciences. Universitat de Barcelona (UB). Barcelona, Spain. Eating Disorders Unit. Department of Psychiatry. Hospital Universitari de Bellvitge. L´Hospitalet de Llobregat, Barcelona. Spain. Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn). Instituto de Salud Carlos III. Madrid, Spain. [Carmezim J] Bellvitge Biomedical Research Institute (IDIBELL). Barcelona, Spain. , [Gornals JB] Endoscopy Unit. Department of Digestive Diseases. Hospital Universitari de Bellvitge. Barcelona, Spain. Bellvitge Biomedical Research Institute (IDIBELL). Barcelona, Spain. Department of Clinical Sciences. School of Medicine and Health Sciences. Universitat de Barcelona (UB). Barcelona, Spain. Faculty of Health Sciences. Universitat Oberta de Catalunya (UOC). Barcelona, Spain, Hospital General de Granollers

    المصدر: Scientia

    وصف الملف: application/pdf

  6. 6

    المساهمون: Institut Català de la Salut, [Burra P] Department of Surgery, Oncology and Gastroenterology, Multivisceral Transplant Unit, Padua University Hospital, Padua, Italy. [Bretthauer M] Department of Health Management and Health Economy, Institute of Health and Society, University of Oslo, Oslo, Norway. [Buti Ferret M] Servei d'Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Dugic A] Department of Gastroenterology, Klinikum Bayreuth Friedrich‐ Alexander‐University Erlangen‐Nürnberg, Bayreuth, Germany. [Fracasso P] Department of Gastroenterology, Ospedale Sandro Pertini, Rome, Italy. [Leja M] Institute of Clinical and Preventive Medicine, University of Latvia and Riga East University Hospital, Riga, Latvia, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  7. 7

    المساهمون: Koessler, Thibaud [0000-0001-9196-9076], Smyth, Elizabeth [0000-0001-6427-229X], Valle, Juan W [0000-0002-1999-0863], Apollo - University of Cambridge Repository, Institut Català de la Salut, [Koessler T] Department of Oncology, Geneva University Hospital, Geneva, Switzerland. Swiss Cancer Center Leman (SCCL), University of Geneva, Lausanne, Switzerland. European Organisation for Research and Treatment of Cancer, Brussel, Belgium. [Alsina M] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Arnold D] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany. [Ben-Aharon I] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Division of Oncology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel. [Lutz MP] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Caritasklinikum, Saarbrucken, Germany. [Obermannova R] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic. Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    British Journal of Cancer
    British journal of cancer, vol. 125, no. 7, pp. 911-919
    The British journal of cancer

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Immunoteràpia, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Cancer immunotherapy, Drug development, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms [DISEASES], Internal medicine, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales [ENFERMEDADES], medicine, Humans, Routine clinical practice, Molecular Targeted Therapy, Aparell digestiu - Càncer - Tractament, Gastrointestinal Neoplasms, Gastrointestinal tract, Clinical Trials as Topic, business.industry, Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], terapéutica::terapia biológica::inmunomodulación::inmunoterapia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Cancer, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Congresses as Topic, medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Colorectal cancer, Survival Analysis, Clinical Practice, Treatment Outcome, Hepatocellular carcinoma, Perspective, Avaluació de resultats (Assistència sanitària), Biliary tract cancer, Human medicine, Immunotherapy, Gastric cancer, business, Early phase

    وصف الملف: application/pdf; text/xml

  8. 8

    المساهمون: Institut Català de la Salut, [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, 08035, Barcelona, Spain. [Bang YJ] Seoul National University College of Medicine, Jongno-gu, Seoul, South Korea. [Van Cutsem E] University Hospitals Gasthuisberg Leuven & KU Leuven, Leuven, Belgium. [Fuchs CS] Yale Cancer Center & Smilow Cancer Hospital, New Haven, CT 06511, USA. [Janjigian YY] Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. [Bhagia P] Merck & Co., Inc., Kenilworth, NJ 07033, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Esophageal Neoplasms, Kaplan-Meier Estimate, Pembrolizumab, Gastroesophageal Junction Adenocarcinoma, chemotherapy, Other subheadings::Other subheadings::/drug therapy [Other subheadings], 0302 clinical medicine, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms [DISEASES], Antineoplastic Combined Chemotherapy Protocols, Multicenter Studies as Topic, RECURRENT, Randomized Controlled Trials as Topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], General Medicine, Middle Aged, OPEN-LABEL, CANCER, Oxaliplatin, Treatment Outcome, Estómac - Càncer - Tractament, Fluorouracil, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, Esophagogastric Junction, immunotherapy, pembrolizumab, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antibodies, Monoclonal, Humanized, Esòfag - Càncer - Tractament, Capecitabine, 03 medical and health sciences, Double-Blind Method, Stomach Neoplasms, first-line therapy, Internal medicine, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales [ENFERMEDADES], medicine, Humans, Response Evaluation Criteria in Solid Tumors, Neoplasm Staging, Cisplatin, Science & Technology, adenocarcinoma, gastroesophageal junction cancer, business.industry, gastric cancer, NIVOLUMAB, Cancer, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], digestive system diseases, 030104 developmental biology, Clinical Trials, Phase III as Topic, Avaluació de resultats (Assistència sanitària), business, HER2-negative

    وصف الملف: application/pdf; Print-Electronic

  9. 9

    المساهمون: Institut Català de la Salut, [Serrano C] Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Sarcoma Translational Research Laboratory, Vall d’Hebron Institute of Oncology, Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mariño-Enríquez A, Tao DL, Eilers G, Zhu M] Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 20 Shattuck Street, Thorn 528, Boston, MA, USA. [Ketzer J] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus

    المصدر: British Journal of Cancer
    Scientia
    Recercat: Dipósit de la Recerca de Catalunya
    Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
    Recercat. Dipósit de la Recerca de Catalunya
    instname

    مصطلحات موضوعية: Cancer Research, Pyridines, Medizin, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Imatinib resistant, Medicaments antineoplàstics, Mice, 0302 clinical medicine, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms [DISEASES], Sunitinib, Gastrointestinal Neoplasms, Sarcoma, Gastrointestinal stromal tumours, 3. Good health, Tracte gastrointestinal - Càncer, Proto-Oncogene Proteins c-kit, Oncology, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, Tyrosine kinase, medicine.medical_specialty, Physiological Phenomena::Pharmacological and Toxicological Phenomena::Pharmacological Phenomena::Drug Resistance::Drug Resistance, Neoplasm [PHENOMENA AND PROCESSES], Gastrointestinal Stromal Tumors, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Mice, Nude, CHO Cells, Predictive markers, Article, 03 medical and health sciences, Clinical Trials, Phase II as Topic, Cricetulus, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales [ENFERMEDADES], medicine, Animals, Humans, neoplasms, Protein Kinase Inhibitors, Resistència als medicaments, fenómenos fisiológicos::fenómenos farmacológicos y toxicológicos::fenómenos farmacológicos::resistencia a medicamentos::resistencia a los antineoplásicos [FENÓMENOS Y PROCESOS], Competing interests, business.industry, Extramural, Phenylurea Compounds, Correction, Xenograft Model Antitumor Assays, digestive system diseases, Drug Resistance, Neoplasm, Family medicine, Mutation, business

    وصف الملف: application/pdf

  10. 10

    المساهمون: Institut Català de la Salut, [Koessler T] Department of Oncology, Geneva University Hospital, Geneva, Switzerland. Swiss Cancer Center Leman (SCCL), University of Geneva, Lausanne, Switzerland. [Alsina M] Hospital Universitario de Navarra (HUN), Medical Oncology Department, Pamplona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Arnold D] Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany. [Ben-Aharon I] Division of Oncology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel. [Collienne M] Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany. European Organisation for Research and Treatment of Cancer, Brussels, Belgium. [Lutz MP] Caritasklinikum, Saarbrucken, Germany, Vall d'Hebron Barcelona Hospital Campus

    المصدر: ESMO Open
    Scientia

    وصف الملف: application/pdf